InterVene

Focus: InterVene is a medical device company specializing in catheter-based therapeutic solutions, headquartered in Redwood City, CA. The company operates in the interventional medical device space with a focused technology platform.

Profile data last refreshed 22h ago · AI intelligence enriched 2w ago

Open Jobs

About InterVene

AI assessmentNot Hiring

No open roles listed right now. Follow InterVene to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

8 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

BlueLeaf® Endovenous Valve Formation System

Chronic Venous Insufficiency (CVI)

N/A

Clinical Trials (1)

NCT04225806Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-US)

N/A

Help build intelligence for InterVene

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Specialized focus on catheter-based therapies in a high-growth interventional device market with clear clinical applications
Redwood City location in Silicon Valley provides access to top talent and proximity to medical device innovation hubs
Opportunity to work on device technologies that directly impact patient outcomes in minimally invasive procedures

Watch Out For

Currently zero active job openings, indicating minimal hiring or possible organizational constraints
Lack of publicly available data on funding status, employee count, and financial performance suggests limited transparency or pre-revenue stage

Generated by Claude from InterVene's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Recana procedure

Venous Obstruction

N/A

Clinical Trials (1)

NCT07095660RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)

N/A

BlueLeaf System

Chronic Venous Insufficiency

N/A

Clinical Trials (1)

NCT03216005Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System

N/A